Literature DB >> 20573808

Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.

Cheng Xu1, Tz-Chun Guo, Stephen Mutoloki, Øyvind Haugland, Inderjit S Marjara, Øystein Evensen.   

Abstract

Salmonid alphavirus (SAV) is an emerging virus in salmonid aquaculture, with SAV-3 being the only subtype found in Norway. Until now, there has been little focus on the alpha interferon (IFN-alpha)-induced antiviral responses during virus infection in vivo or in vitro in fish. The possible involvement of IFN-gamma in the response to SAV-3 is also not known. In this study, the two IFNs were cloned and expressed as recombinant proteins (recombinant IFN-alpha [rIFN-alpha] and rIFN-gamma) and used for in vitro studies. SAV-3 infection in a permissive salmon cell line (TO cells) results in IFN-alpha and IFN-stimulated gene (ISG) mRNA upregulation. Preinfection treatment (4 to 24 h prior to infection) with salmon rIFN-alpha induces an antiviral state that inhibits the replication of SAV-3 and protects the cells against virus-induced cytopathic effects (CPE). The antiviral state coincides with a strong expression of Mx and ISG15 mRNA and Mx protein expression. When rIFN-alpha is administered at the time of infection and up to 24 h postinfection, virus replication is not inhibited, and cells are not protected against virus-induced CPE. By 40 h postinfection, the alpha subunit of eukaryotic initiation factor 2 (eIF2alpha) is phosphorylated concomitant with the expression of the E2 protein as assessed by Western blotting. Postinfection treatment with rIFN-alpha results in a moderate reduction in E2 expression levels in accordance with a moderate downregulation of cellular protein synthesis, an approximately 65% reduction by 60 h postinfection. rIFN-gamma has only a minor inhibitory effect on SAV-3 replication in vitro. SAV-3 is sensitive to the preinfection antiviral state induced by rIFN-alpha, while postinfection antiviral responses or postinfection treatment with rIFN-alpha is not able to limit viral replication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573808      PMCID: PMC2919011          DOI: 10.1128/JVI.00851-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Evolutionary relationships and systematics of the alphaviruses.

Authors:  A M Powers; A C Brault; Y Shirako; E G Strauss; W Kang; J H Strauss; S C Weaver
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Rainbow trout sleeping disease virus is an atypical alphavirus.

Authors:  S Villoing; M Béarzotti; S Chilmonczyk; J Castric; M Brémont
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection.

Authors:  Elena I Frolova; Rafik Z Fayzulin; Susan H Cook; Diane E Griffin; Charles M Rice; Ilya Frolov
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Pathogenesis and immune response in Atlantic salmon (Salmo salar L.) parr experimentally infected with salmon pancreas disease virus (SPDV).

Authors:  L Desvignes; C Quentel; F Lamour; Ven A le
Journal:  Fish Shellfish Immunol       Date:  2002-01       Impact factor: 4.581

Review 6.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Comparison of two aquatic alphaviruses, salmon pancreas disease virus and sleeping disease virus, by using genome sequence analysis, monoclonal reactivity, and cross-infection.

Authors:  Jonathan Weston; Stéphane Villoing; Michel Brémont; Jeanette Castric; Martin Pfeffer; Victoria Jewhurst; Marian McLoughlin; OddMagne Rødseth; Karen Elina Christie; Joseph Koumans; Daniel Todd
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Expression of interferon and interferon--induced genes in Atlantic salmon Salmo salar cell lines SHK-1 and TO following infection with Salmon AlphaVirus SAV.

Authors:  Suresh K Gahlawat; Anthony E Ellis; Bertrand Collet
Journal:  Fish Shellfish Immunol       Date:  2009-03-03       Impact factor: 4.581

9.  Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff.

Authors:  Jason D Simmons; Laura J White; Thomas E Morrison; Stephanie A Montgomery; Alan C Whitmore; Robert E Johnston; Mark T Heise
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses.

Authors:  Jun Yin; Christina L Gardner; Crystal W Burke; Kate D Ryman; William B Klimstra
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

View more
  27 in total

1.  A single amino acid mutation (I1012F) of the RNA polymerase of marine viral hemorrhagic septicemia virus changes in vitro virulence to rainbow trout gill epithelial cells.

Authors:  Sung-Hyun Kim; Beate J Thu; Helle F Skall; Niccolò Vendramin; Oystein Evensen
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

2.  Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.

Authors:  Masataka Tsuge; Takuro Uchida; Nobuhiko Hiraga; Hiromi Kan; Grace Naswa Makokha; Hiromi Abe-Chayama; Daiki Miki; Michio Imamura; Hidenori Ochi; C Nelson Hayes; Rieko Shimozono; Tomokatsu Iwamura; Hideki Narumi; Tomohiko Suzuki; Mie Kainoh; Tadatsugu Taniguchi; Kazuaki Chayama
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

3.  Antiviral activity of salmonid gamma interferon against infectious pancreatic necrosis virus and salmonid alphavirus and its dependency on type I interferon.

Authors:  Baojian Sun; Ingrid Skjæveland; Tina Svingerud; Jun Zou; Jorunn Jørgensen; Børre Robertsen
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

4.  Development of infectious cDNA clones of Salmonid alphavirus subtype 3.

Authors:  Marius Karlsen; Stephane Villoing; Karl F Ottem; Espen Rimstad; Are Nylund
Journal:  BMC Res Notes       Date:  2010-09-21

5.  Stress-induced reversion to virulence of infectious pancreatic necrosis virus in naïve fry of Atlantic salmon (Salmo salar L.).

Authors:  Koestan Gadan; Ane Sandtrø; Inderjit S Marjara; Nina Santi; Hetron M Munang'andu; Øystein Evensen
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

6.  The C-Terminal Domain of Salmonid Alphavirus Nonstructural Protein 2 (nsP2) Is Essential and Sufficient To Block RIG-I Pathway Induction and Interferon-Mediated Antiviral Response.

Authors:  Raphaël Jami; Emilie Mérour; Julie Bernard; Annie Lamoureux; Jean K Millet; Stéphane Biacchesi
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

7.  A polyprotein-expressing salmonid alphavirus replicon induces modest protection in atlantic salmon (Salmo salar) against infectious pancreatic necrosis.

Authors:  Azila Abdullah; Christel M Olsen; Kjartan Hodneland; Espen Rimstad
Journal:  Viruses       Date:  2015-01-19       Impact factor: 5.048

8.  Gene expression studies of host response to Salmonid alphavirus subtype 3 experimental infections in Atlantic salmon.

Authors:  Cheng Xu; Tz-Chun Guo; Stephen Mutoloki; Oyvind Haugland; Oystein Evensen
Journal:  Vet Res       Date:  2012-11-01       Impact factor: 3.683

9.  A 6K-deletion variant of salmonid alphavirus is non-viable but can be rescued through RNA recombination.

Authors:  Tz-Chun Guo; Daniel X Johansson; Øyvind Haugland; Peter Liljeström; Øystein Evensen
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

10.  De novo assembly and transcriptome analysis of Atlantic salmon macrophage/dendritic-like TO cells following type I IFN treatment and Salmonid alphavirus subtype-3 infection.

Authors:  Cheng Xu; Øystein Evensen; Hetron Mweemba Munang'andu
Journal:  BMC Genomics       Date:  2015-02-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.